4-Hydroxycinnamate lowers plasma and hepatic lipids without changing antioxidant enzyme activities

Annals of Nutrition and Metabolism

Volumn 47, Issue 3-4, 2003, Pages 144-151

  Lee, Jeong Sun ^a   Bok, Song Hae ^b   Park, Yong Bok ^a   Lee, Mi Kyung ^a   Choi, Myung Sook ^a  

^a Kyungpook National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

4 Hydroxycinnamate; Antioxidant enzymes; Cholesterol metabolism

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ANTIOXIDANT; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; ENZYME; FAT DROPLET; LIPID; MEVINOLIN; PARA COUMARIC ACID; STEROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FECES ANALYSIS; FEEDING; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPID METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTILIPEMIC AGENTS; ANTIOXIDANTS; BODY WEIGHT; CHOLESTEROL, DIETARY; COUMARIC ACIDS; EATING; ENZYMES; FECES; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIPID METABOLISM; LIPIDS; LIVER; LOVASTATIN; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; STEROL O-ACYLTRANSFERASE; STEROLS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0038246502     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070037     Document Type: Article

References (56)

1. Smith GD, Shipley MJ, Marmot MG, Rose G: Plasma cholesterol concentration and mortality. The Whitehall Study. JAMA 1992;267:70-76.
2. Kannel WB, Castelli WP, Gordon T, McNamara PM: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 1971;74:1-12.
3. Visioli F, Galli C: Antiatherogenic components of olive oil. Curr Atheroscler Rep 2001;3:64-67.
4. Mojzisová G, Kuchta M: Dietary flavonoids and risk of coronary heart disease. Physiol Res Acad Sci Bohemosl 2001;50:529-535.
5. Morton LW, Abu-Amsha Caccetta R, Puddey IB, Croft KD: Chemistry and biological effects of dietary phenolic compounds: Relevance to cardiovascular disease. Clin Exp Pharmacol Physiol 2000;27:152-159.
6. Noguchi N, Niki E: Phenolic antioxidants: A rationale for design and evaluation of novel antioxidant drug for atherosclerosis. Free Rad Biol Med 2000;28:1538-1546.
7. Owen RW, Giacosa A, Hull WE, Haubner R, Würtele G, Spiegelhalder B, Bartsch H: Olive-oil consumption and health: The possible role of antioxidants. Lancet Oncol 2000;i:107-112.
8. Alberts AW, Chen J, Kuron G, Hunt V, Huff J, Hoffman C, Rothrock J, Lopez M, Joshua H, Harris E, Patchett A, Monaghan R, Currie S, Stapley E, Albers-Schonberg G, Hensens O, Hirshfield J, Hoogsteen K, Liesch J, Springer J: Mevinolin: A highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci USA 1980;77:3957-3961.
9. Amin D, Gustafson SK, Weinacht JM, Cornell SA, Neuenschwander K, Kosmider B, Scotese AC, Regan JR, Perrone MH: RG 12561 (dalvastatin): A novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent. Pharmacology 1993;46:13-22.
10. Alberts AW: Discovery, biochemistry and biology of lovastatin. Am J Cardiol 1988;62:10J-15J.
11. Fujioka T, Nara F, Tsujita Y, Fukushige J, Fukami M, Kuroda M: The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats. Biochim Biophys Acta 1995;1254:7-12.
12. Lovastatin Study Groups I through IV. Lovastatin 5-year safety and efficacy study. Arch Intern Med 1993;153:1079-1087.
13. Chang TY, Chang CC, Cheng D: Acyl-coenzyme A:cholesterol acyltransferase. Ann Rev Biochem 1997;66:613-638.
14. Warner GJ, Stoudt G, Bamberger M, Johnson WJ, Rothblat GH: Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol. J Biol Chem 1995;270:5772-5778.
15. Tabas I, Marathe S, Keesler GA, Beatini N, Shiratori Y: Evidence that the initial up-regulation of phosphatidylcholine biosynthesis in free cholesterol-loaded macrophages is an adaptive response that prevents cholesterol-induced cellular necrosis: Proposed role of an eventual failure of this response in foam cell necrosis in advanced atherosclerosis. J Biol Chem 1996;271:22773-22781.
16. Kellner-Weibel G, Jerome WG, Small DM, Warner GJ, Stoltenborg JK, Kearney MA, Corjay MH, Phillips MC, Rothblat GH: Effects of intracellular free cholesterol accumulation on macrophage viability: A model for foam cell death. Arterioscler Thromb Vasc Biol 1998;18:423-431.
17. Zhang HY, Ge N, Zhang ZY: Theoretical elucidation of activity differences of five phenolic antioxidants. Acta Pharmacol Sin 1999;20:363-366.
18. Bourne LC, Rice-Evans C: Bioavailability of ferulic acid. Biochem Biophys Res Commun 1998;253:222-227.
19. Yugarani T, Tan BK, Teh M, Das NP: Effects of polyphenolic natural products on the lipid profiles of rats fed high fat diets. Lipids 1992;27:181-186.
20. Sharma RD: Isoflavones and hypercholesterolemia in rats. Lipids 1979;14:535-539.
21. Zang LY, Cosma G, Gardner H, Shi X, Castranova V, Vallyathan V: Effect of antioxidant protection by p-coumaric acid on low-density lipoprotein cholesterol oxidation. Am J Physiol Cell Physiol 2000;279:C954-C960.
22. 2-dependent low density lipoprotein lipid peroxidation by naturally occurring phenolic acids. Biochem Pharmacol 1996;51:395-402.
23. Laranjinha J, Vieira O, Madeira V, Almeida L: Two related phenolic antioxidants with opposite effects on vitamin E content in low density lipoproteins oxidized by ferrylmyoglobin: Consumption vs. regeneration. Arch Biochem Biophys 1995;323:373-381.
24. Loake GJ, Faktor O, Lamb CJ, Dixon RA: Combination of H-box [CCTACC(N)7CT] and G-box(CACGTG) cis elements is necessary for feed-forward stimulation of a chalcone synthase promoter by the phenylpropanoid-pathway intermediate p-coumaric acid. Proc Natl Acad Sci USA 1992;89:9230-9234.
25. Castelluccio C, Bolwell GP, Gerrish C, Rice-Evans C: Differential distribution of ferulic acid to the major plasma constituents in relation to its potential as an antioxidant. Biochem J 1996;316:691-694.
26. American Institute of Nutrition: Report of the American Institute of Nutrition. Ad Hoc Committee on standards for nutritional studies. J Nutr 1977;107:1340-1348.
27. American Institute of Nutrition: Report of Ad Hoc Committee on standards for nutritional studies. J Nutr 1980;110:1717-1726.
28. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-475.
29. Warnick GR, Albers JJ: A comprehensive evaluation of the heparin-manganease precipitation procedure for estimating a high density lipoprotein cholesterol. J Lipid Res 1978;19:65-76.
30. McGowan MW, Artiss JD, Strandbergh DR, Zak B: A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 1983;29:538-542.
31. Folch J, Lees M, Sloan-Stanley GH: A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497-509.
32. Hulcher FH, Oleson WH: Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. J Lipid Res 1973;14:625-631.
33. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
34. Shapiro DJ, Nordstrom JL, Mitschelen JJ, Rodwell VW, Schimke RT: Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts. Biochim Biophys Acta 1974;370:369-377.
35. Erickson SK, Schrewsbery MA, Brooks C, Meyer DJ: Rat liver acyl-coenzyme A:cholesterol acyltransferase: Its regulation in vivo and some of properties in vitro. J Lipid Res 1980;21:930-941.
36. Gillies PJ, Rathgeb KA, Perri MA, Robinson CS: Regulation of Acyl-CoA:cholesterol acyltransferase activity in normal and atherosclerotic rabbit aortas: Role of a cholesterol substrate pool. Exp Mol Pathol 1986;44:320-339.
37. Czubayko F, Beumers B, Lammsfuss S, Lutjohann D, von Bergmann K: A simplified micromethod for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. J Lipid Res 1992;32:1861-1867.
38. Crowell MJ, Macdonald IA: Enzymic Determination of 3α-, 7α-, and 12α-hydroxyl groups of fecal bile salts. Clin Chem 1980;26:1298-1300.
39. Marklund S, Marklund G: Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47:469-474.
40. Aebi H: Catalase; in: Method of Enzymatic Analysis. New York, Academic Press, 1974, vol 2, pp 673-684.
41. Paglia ED, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocytes glutathione peroxidase. J Lab Clin Med 1967;70:158-169.
42. Ohkawa H, Ohishi N, Yogi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
43. Zang LY, Cosma G, Gardner H, Shi X, Castranova V, Vallyathan V: Effect of antioxidant protection by p-coumaric acid on low-density lipoprotein cholesterol oxidation. Am J Physiol Cell Physiol 2000;279:C954-C960.
44. Lee JS, Choi MS, Jeon SM, Jeong TS, Park YB, Lee MK, Bok SH: Lipid-lowering and antioxidative activities of 3,4-di(OH)-cinnamate and 3,4-di(OH)-hydrocinnamate in cholesterol-fed rats. Clin Chim Acta 2001;314:221-229.
45. Fears R, Richards DH, Ferres H: The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks. Atherosclerosis 1980;35:439-449.
46. Endo A, Tsujita Y, Kuroda M, Tanzawa K: Effects of ML-236B on cholesterol metabolism in mice and rats: Lack of hypocholesterolemic activity in normal animals. Biochim Biophys Acta 1979;575:266-276.
47. Ma PTS, Gil G, Sudhog TC, Bilheimer DW, Goldstein JL, Brown MS: Mevinolin, and inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits. Proc Natl Acad Sci USA 1986;83:8370-8374.
48. Alberts AW: Discovery, biochemistry and biology of lovastatin. Am J Cardiol 1988;62:10J-15J.
49. Tall AR: Plasma cholesteryl ester transfer protein. J Lipid Res 1993;34:1255-1274.
50. Amin D, Gustafson SK, Weinacht JM, Cornell SA, Neuenschwander K, Scotese AC, Regan JR, Perrone MH: RG 12561 (Dalvastatin): A novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent. Pharmacology 1993;46:13-22.
51. Shand JH, West DW: The effects of simvastatin and cholestyramine, alone and in combination, on hepatic cholesterol metabolism in the male rats. Lipids 1995;30:917-926.
52. Harris WS, Dujovne CA, von Bergmann K, Neal J, Akester J, Windsor SL, Greene D, Look Z: Effects of the ACAT inhibitor CL 227,082 on cholesterol metabolism in human. Clin Pharmacol Ther 1990;48:189-194.
53. Kurowska EM, Borradaile NM, Spence JD, Carroll KK: Hypocholesterolemic effects of dietary citrus juices in rabbits. Nutr Res 2000;20:121-129.
54. Yoshino M, Murakami K: Interaction of iron with polyphenolic compounds: Application to antioxidant characterization. Analyt Biochem 1998;257:40-44.
55. Nardini M, D'Aquino M, Tomassi G, Gentili V, Di Felice M, Scaccini C: Inhibition of human low-density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives. Free Rad Biol Med 1995;19:541-552.
56. Chalas J, Claise C, Edeas M, Messaoudi C, Vergnes L, Abella A, Lindenbaum A: Effect of ethyl esterification of phenolic acids on low-density lipoprotein oxidation. Biomed Pharmacother 2001;55:54-60.